Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen

标题
Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen
作者
关键词
Breast cancer, HER2, Lapatinib, <em class=EmphasisTypeItalic >Nab</em>-paclitaxel
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume 137, Issue 2, Pages 457-464
出版商
Springer Nature
发表日期
2012-12-07
DOI
10.1007/s10549-012-2341-9

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More